Epidemiology of Young Lung Cancer Study
Epidemiology of Young Lung Cancer Study
Update: As of March 2022, this study is now open to all people with NSCLC who were diagnosed under age 50.
Epidemiology of Young Lung Cancer is a clinical study for patients who were diagnosed with non-small cell lung cancer before age 50.
Want more information about this study?
Click to open PDF
Description of Study
This study seeks to help researchers and clinicians better understand why an increasing number of young people are developing lung cancer. Specifically, we are looking to study the environmental and childhood exposures, and other risk factors for lung cancer in persons under age 50.
Study Eligibility
This study is open to adults who were diagnosed with lung cancer before age 50 and have completed comprehensive biomarker testing. Only individuals who live in the United States are eligible.
The best way to determine eligibility is to fill out the form below. A member of our study team will get in touch with you to review the eligibility requirements and go over everything that will happen during the study.
How It Works
Once your eligibility is determined, we will ask you to fill out an online survey of approximately 200 questions to capture information about your demographics, medical history, active and passive smoking history, early life exposures, residential and occupational history, menstrual and reproductive history (if applicable), and diet and physical activity. You will also have the option to invite your birth mother (or father) to participate in the study. In addition, you will provide a small sample of blood. You will be able to choose your own provider to collect the sample or we can arrange for the sample to be collected at your home.
Feel free to contact us at 888-44-EOYLC (888-443-6952) with any questions.
Sign-Up Form
Please fill out the form below if you are interested in learning more about this clinical study. Filling out the form does not require you to participate in the study. Eligibility will be determined after speaking with a member of our study team and a review of your medical records.